Organization
Hospital Clinico San Carlos
4 abstracts
Abstract
Operability changes in patients with NSCLC after neoadjuvant chemotherapy and anti-PD-1/PD-L1.Org: Hospital Clinico San Carlos, Hospital Clínico Universitario de Valladolid, University Hospital Fundación Jiménez Díaz, Ramon y Cajal University Hospital, Hospital Severo Ochoa,
Abstract
SELISARC: A Spanish Sarcoma Group (GEIS) phase I/II trial of selinexor plus gemcitabine in selected sarcoma subtypes—Results of the phase I part.Org: Fundacion Jimenez Diaz University Hospital, Hospital Clinico San Carlos, Health Research Institute-Fundación Jiménez Díaz University Hospital, Hospital Universitario La Paz - CIBERONC, Hospital U. Miguel Servet,
Abstract
Efficacy analysis of CDK4/6 inhibitors (CDKi) + endocrine therapy (ET) treatment in hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer (aBC): Biomarker analysis including chemoendocrine score (CES) by CDKi type in SOLTI-1801_CDK-PREDICT study.Org: Medical Oncology Department, Presidio Ospedaliero Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy, Hospital 12 de Octubre, Hospital Clínic de Barcelona, IDIBAPS, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), SOLTI Breast Cancer Cooperative Group,
Abstract
Prognostic value of human leukocyte antigen G (HLA-G) expression in solid tumors: A systematic review and meta-analysis.Org: Hospital Clinico San Carlos, IdISSC, Velindre Cancer Centre, Velindre University NHS Trust, Clinica Universidad de Navarra, Princess Margaret Cancer Centre,